Medical Affairs Platform & Strategy
Mitigating the growing numbers of risks of post-approval activities has many hurdles and is a critical task for life sciences companies. Furthermore, organizations require results-proven professionals to develop a strategy that aligns medical affairs activities with core business goals and that is supported by real-world evidence (RWE).
At Baker Tilly, our experienced life sciences industry specialists have foresight into the future state of medical affairs and provide the strategic lens that medical device and pharmaceutical companies need to achieve success now, and for tomorrow. Our specialized professionals understand the intricacies of navigating the complex demands of physicians, hospitals and hospital systems, and health plans to help organizations disseminate accurate and effective information on product value. These solutions take into account compliance and accreditation standards, key opinion leader (KOL) management, medical information and education, and evidence generation in developing comprehensive medical affairs strategies.
Baker Tilly’s medical affairs strategy and enablement services assist companies in balancing clinical communications with novel evidence generation. Thoughtful program design and execution enables our clients to sustain market penetration from launch through the product lifecycle. Our approach includes:
Baker Tilly’s focus on being a Value Architect™ means our medical affairs solutions are derived from data-driven insights that help mitigate some of the largest risks to medical affairs success. Our team offers a comprehensive set of solutions to help our clients and to achieve their medical affairs goals.
Baker Tilly helps companies improve the implementation of key activities to increase efficiency and reduce time, resource wastage and mistakes, including:
Our deep understanding of compliance assists life sciences companies with their effort to remain compliant with local, federal and global regulatory bodies throughout the product life cycle, including:
Our experience enables life sciences companies to develop and implement systems to more effectively assess and manage investigator initiated trials (IITs), including:
Our deep industry relationships uniquely enable us to connect life science companies with industry leading KOLs and develop mutually beneficial collaborations, including:
We have experience assisting life sciences companies comply with local, federal and global regulatory bodies throughout the product life cycle and help companies through:
With our wide range of experience, we help life sciences companies more efficiently and effectively store, disseminate and monitor their medical information, including:
Our knowledge of care pathways enables us to help life sciences companies develop a well-rounded view of how and where patients receive treatment, including:
Our deep analytical experience helps life sciences companies generate meaningful RWE to demonstrate value and expand product use, including:
Through our deep understanding of the needs of life science research driven by external partners, we help life sciences companies establish and maintain mutually beneficial relationships with external organizations to support product value, including: